Date : Friday, 02 May 2025
Start Time : 08:30
End Time : 10:30
Location : Hall 2
Brief Communications
Chairs
Fattahzadeh Ghasem
Maghsoudlou E.
Farzi M A
Ghazanfari Dr.
Rahimi Shiva
Presentations
08:30 | CNS Involvement In Atypical Systemic Lymphoma
Cu
08:40 | Evaluating The Effect Of L-carnitine Supplement On Fatigue Severity In Patients With Multiple Sclerosis
Cu
08:50 | Intravenous Thrombolysis In Patients Taking Direct Oral Anticoagulation Treatment Before Stroke Onset
Cu
09:00 | Neurological Immune-Related Adverse Events In Patients Treated With Anti-PD-1 Agent, Pembrolizumab: A Case Series
Cu
09:10 | Preventive Medications In Pediatric Migraine A Network Meta-Analysis
Cu
09:20 | Cognitive Rehabilitation In Multiple Sclerosis And Systemic Lupus Erythematosus: A Pathway To Improved Cognitive Function And Quality Of Life
Cu
09:30 | Comprehensive Review Of The Cardiovascular Complications Of The FDA-approved Anti-MS Modifying Therapies
Cu
09:40 | Updates In Poststroke Epilepsy And Its Prediction
Cu
09:50 | Is It Time To Prolong Dual Antiplatelet Therapy Using De-escalation Strategy In Minor Ischemic Stroke? Evidence From One-year Follow-up Analysis Of TACAMINIS Study
Cu
10:00 | Evaluation Of The Efficacy Of Fingolimod And Alteplase Combination In Treatment Of Acute Ischemic Stroke
Cu
10:10 | Ghost Tumor In Central Nervous System; A Case Report And Narrative Review
Cu
10:20 | A Hybrid Machine Learning And Deep Learning Approach For Intracerebral Hemorrhage Detection On CT-Scan Images
Cu